Model
Edge
Ultragenyx Pharmaceutical Inc.
0001603347
Filing Type
4
Filing Date
12/10/2024
Updated
12/11/24, 4:47 PM
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership